| NPI | Name | Type | Address |
|---|---|---|---|
|
MS. PHARMD Linda Sumiko Namba-garcia |
Individual |
7373 West Ln Stockton, CA |
|
|
PHARMD Wei-hsuan Tai |
Individual |
3855 Health Sciences Dr La Jolla, CA |
|
|
PHARMD Yuchih E Tang |
Individual |
3855 Health Sciences Dr La Jolla, CA |
|
|
PHARMD/PH.D. Ji Sun |
Individual |
9452 Medical Center Dr Rm 1e314 La Jolla, CA |
|
|
DR. Sarah G Walden |
Individual |
3701 Broadway Oakland, CA |
|
|
RPH Elle Eunyounglee Kim |
Individual |
7300 N Fresno St Fresno, CA |
|
|
PHARMD John Ericson Margallo |
Individual |
757 Westwood Plz # B140 Los Angeles, CA |
|
|
DR. PHARMD, BCOP Maria Josefina Arella |
Individual |
3883 Airway Dr Ste 320 Santa Rosa, CA |
|
|
Tahir Ashraf |
Individual |
6600 Bruceville Rd Sacramento, CA |
|
|
PHARM.D. Chieko Otomo |
Individual |
4647 Zion Ave Oncology Pharmacy Room 4825 San Diego, CA |
|
|
Parwinder Purewal |
Individual |
3555 Round Barn Circle Santa Rosa, CA |
|
|
DR. PHARMD Chihara O Talavera |
Individual |
3883 Airway Dr Santa Rosa, CA |
|
|
PHARMD Angie Luong |
Individual |
16133 Ventura Blvd Encino, CA |
|
|
Chiugo Okeke |
Individual |
3855 Health Sciences Dr La Jolla, CA |
|
|
PHARMD Helena Thai Nhi Hoang |
Individual |
2080 Century Park E Ste 803 Los Angeles, CA |
|
|
PHARMD Min Jung Lee |
Individual |
9090 Wilshire Blvd Ste 250 Beverly Hills, CA |
|
|
DR. PHARM.D. Eileen Holovac |
Individual |
11201 Benton St Loma Linda, CA |
|
|
PHARMD Nick Lin |
Individual |
11047 Camino Playa Carmel San Diego, CA |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |